Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by fluorescent microscopy of cytochalasin B-blocked micronucleus formation

Journal of Applied Toxicology

Volumn 34, Issue 11, 2014, Pages 1200-1208

  Sahu, Saura C ^a   Roy, Shambhu ^c   Zheng, Jiwen ^b   Yourick, Jeffrey J ^a   Sprando, Robert L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^c BioReliance Corporation   (United States)

Author keywords

Caco2 cells; Cytochalasin B blocked micronucleus assay; Genotoxicity; HepG2 cells; in vitro micronucleus assay; Nanoparticles; Nanosilver; Silver nanoparticles

Indexed keywords

ACRIDINE ORANGE; CYTOCHALASIN B; SILVER NANOPARTICLE; METAL NANOPARTICLE; SILVER;

ARTICLE; CACO 2 CELL LINE; COLON; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DYNAMICS; EXPOSURE; FLUORESCENCE MICROSCOPY; GENOTOXICITY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIGHT SCATTERING; LIVER; MASS SPECTROMETRY; MICRONUCLEUS; MICRONUCLEUS TEST; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; CYTOLOGY; DNA DAMAGE; DRUG EFFECTS; PARTICLE SIZE;

CACO-2 CELLS; COLON; CYTOCHALASIN B; DNA DAMAGE; HEP G2 CELLS; HUMANS; LIVER; METAL NANOPARTICLES; MICRONUCLEUS TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PARTICLE SIZE; SILVER;

EID: 84907876796     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3028     Document Type: Article

References (82)

1. AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3: 279-290.
2. st century: Bringing the vision to life. Toxicol. Sci. 107: 324-330.
3. Avalos A, Haza AI, Mateo D, Morales P. 2013. Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells. J. Appl. Toxicol. DOI: 10.1002/jat.2957.
4. Bazin E, Mourot A, Humpage AR, Fessard V. 2010. Genotoxicity of a freshwater cyanotoxin, cylindrospermopsin, in two human cell lines: Caco-2 and HepaRG. Environ. Mol. Mutagen. 51: 251-259.
5. Becker H, Herzberg F, Schulte A, Kolossa-Gehring M. 2011.The carcinogenic potential of nanomaterials, their release from products and options for regulating them. Int. J. Hyg. Environ. Health 214: 231-238.
6. Bohmert L, Niemann B, Thunemann AF, Lampen A. 2012. Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco2. Arch. Toxicol. 86: 1107-1115.
7. Bouwmeester H, Poortman JH, Peters RJB, Wijma E, Kramer EHM, Makama S, Puspitaninganindita K, Marvin HJP, Peijnenburg AACM, Hendriksen PJM. 2011. Characterization of Translocation of Silver Nanoparticles and Effects on Whole-Genome Gene Expression Using an In Vitro Intestinal Epithelium Coculture Model. ACS Nano 5: 4091-4103.
8. Brandon EFA, Bosch TM, Deenen MJ, Levink R, van der Wal E, van Meerveld JBM, Bijl M, Beijnen JH, Schellen JHM, Meijerman I. 2006. Validation of in vitro cell models used in drug metabolism and transport studies: genotypning of cytochrome P450 and drug transporter polymorphism in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (Caco2, LS180) cell lines. Toxicol. Appl. Pharmacol. 211: 1-10.
9. Bryce SM, Avlasevich SL, Bemis JC, Lukamowicz M, Elhajouji A, Van Goethem F, De Boeck M, Beerens D, Aerts H, Van Gompel J, Collins JE, Ellis PC, White AT, Lynch AM, Dertinger SD. 2008. Interlaboratory evaluation of a flow cytometric high content in vitro micronucleus assay. Mutat. Res. 650: 181-195.
10. Bryce SM, Shi J, Nicolette J, Diehl, Sonders P, Avlasevich S, Raja S, Bemis JC, Dertinger SD. 2010. High content flocytometric micronucleus scoring method is applicable to attachment cells lines. Environ. Mol. Mutagen. 51: 360-266.
11. Buerki-Thurnherr T, Xiao L, Diener L, Arslan O, Hirsch C, Maeder-Althaus X, Grieder K, Wampfler B, Mathur S, Wick P, Krug HF. 2013. In vitro mechanistic study towards a better understanding of ZnO nanoparticle toxicity. Nanotoxicology 7: 402-426.
12. st century: A view from the chemical industry. Toxicol. Sci.112:: 297-302.
13. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. 1988. Epithelial polarity, villin expression and enterocytic differentiation of cultured human colon carcinoma cells: A survey of twenty cell lines. Cancer Res. 48: 1936-1942.
14. Chopra DP, Dombkowski AA, Stemmer PM, Parker GC. 2010. Intestinal epithelial cells in vitro. Stem Cells Dev. 19: 131-142.
15. Circu ML, Aw TY. 2010. Reactive oxygen species, cellular redox systems and apoptosis. Free Radic. Biol. Med. 48: 749-762.
16. Colognato R, Bonelli A, Ponti J, Farina M, Beramaschi E, Sabbion E, Migliore L. 2008. Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis 23 (5): 377-382.
17. Dashti N, Wolfbaurer G, Koren E, Knowles B, Alanpovic P. 1984. Catabolism of human low density lipoproteins by human hepatoma cell line HepG2. Biochim. Biophys. Acta 794: 373-384.
18. Dierickx PJ. 1987. Inhibition of glutathione-dependent uridine uptake in cultured human hepatoma cells. Med. Sci. Res. 15: 1349-1350.
19. Dudas J, Mansuroglu T, Moriconi F, Haller F, Wilting J, Lorf T, Fuzes L, Ramadori G. 2008. Altered regulation of Prox1-gene-expression in liver tumors. BMC Cancer 8: 92-106.
20. Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, Oczkowski M, Krawczyńska A, Chwastowska J, Sadowska- Bratek M, Chajduk E, Wojewódzka M, Dušinská M, Kruszewski M. 2012. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J. Appl. Toxicol. 32: 920-928.
21. Eom H, Choi J. 2010. P38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanssims of toxicity of silver nanoparticles in Jurkat T cells. Environ. Sci. Technol. 44: 8337-8342.
22. Elder A, Gelein R, Finkelstein JN, Driscoll KE, Harkema J, Oberdorster G. 2005. Effects of inhaled carbon black in three species: Retention kinetics, lung inflammation and histopathology. Toxicol. Sci. 88: 614-629.
23. Fang J, Beland FA. 2009. Long-term exposure to Zidovudine delays cell cycle progression, induces apoptosis and decreases telomerase activity in human hepatocytes. Toxicol. Sci. 111: 120-130.
24. Faunce T, Watal A. 2010. Nanosilver and global public health: International regulatory issues. Nanomedicine 5: 617-632.
25. Fenech M, Crott J, Turner J, Brown S. 1999. Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within cytokinesis-block micronucleus assay: Description of the method and results for hydrogen peroxide. Mutagenesis 14: 605-612.
26. Fenech M. 2000. The in vitro micronucleus technique. Mutat. Res. 455: 81-95.
27. Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2: 1084-1104.
28. Fowler P, Whitwell J, Jeffrey L, Young J, Smith K, Kirkland D. 2010. Etoposide, colchicine, mitomycin C and cyclophosphamide tested in the in vitro mammalian cell micronucleus test (MNvit) in Chinese hamster lung (CHL) cells at Covance laboratories; Harrogate UK in support of OECD draft Test Guideline 487. Mutat. Res. 702: 175-180.
29. Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, Haberl N, Brunelli A, Kreyling WG, Stone V. 2013. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol. Sci. 131: 537-547.
30. Gerloff K, Albrecht C, Boots AW, Forster I, Schins RPF. 2009. Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco2 cells. Nanotoxicology 3: 355-364.
31. Gerloff K, Pereira D, Faria N, Boots AW, Kolling J, Forster I, Albrecht C, Powell JJ, Schins RPF. 2013. Influence of simulated gastrointestinal conditions on particle-induced cytotoxicity and interleukin-8 regulation in differentiated and undifferentiated Caco2 cells. Nanotoxicology 7: 353-366.
32. Haase A, Rott S, Mantion A, Graf P, Plendl J, Thunemann A, Meier W, Taubert A, Luch A, Reiser G. 2012. Effects of silver nanoparticles on primary mixed neural cell cultures: Uptake, oxidative stress and acute calcium responses. Toxicol. Sci. 126: 457-468.
33. Harris AJ, Dial SL, Casciano DA. 2004. Comparision of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mutat. Res. 549: 79-99.
34. Hartung T, Daston G. 2009. Are in vitro tests suitable for regulatory use? Toxicol. Sci. 111: 23-27.
35. Horev-Azaria L, Kirkpatrick CJ, Korenstein R, Marche PN, Maimon O, Ponti J, Romano R, Rossi F, Golla-Schindler U, Sommer D, Uboldi C, Unger RE, Villiers C. 2011. Predictive toxicology of cobalt nanoparticles and ions: Comparative in vitro study of different cellular models using methods of knowledge discovery from data. Toxicol. Sci. 122: 489-501.
36. Jennen DG, Magkoufopoulou C, Ketelslegers HB, van Herwijnen MH, Kleinjans JC, van Delft JH. 2010. Comparison of HepG2 and HepaRG by whole genome gene expression analysis for the purpose of chemical hazard identification. Toxicol. Sci. 115: 66-79.
37. Jennifer M, Maciej W. 2013. Nanoparticle technology as a double-edged sword: Cytotoxic, genotoxic and epigenetic effects on living cells. J. Biomater. Nanobiotechnol. 4: 53-63.
38. Jin X, Chen Q, Tang S, Zou J, Chen K, Zhang T, Xiao X. 2009. Investigation of quinocetone-induced genotoxicity in HepG2 cells using the comet assay, cytokinesis-block micronucleus test and RAPD analysis. Toxicol. In Vitro 23: 1209-1214.
39. Kang M, Lim C, Han J. 2013. Comparison of toxicity and deposition of nano-sized carbon black aerosol prepared with and without dispersing sonication. Toxicol. Res. 29: 121-127.
40. Kao Y, Chen Y, Cheng T, Chiung Y, Liu P. 2012. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol. Sci. 125: 462-472.
41. Kawanishi M, Watanabe T, Hagio S, Ogo S, Shimohara C, Jouchi R, Takayama S, Hasei T, Hirayama T, Oda Y, Yagi T. 2009. Genotoxicity of 3, 6-dinitrobenzo[e]pyrene, a novel mutagen in ambient air and surface soil, in mammalian cells in vitro and in vivo. Mutagenesis 24: 279-284.
42. Kawata K, Osawa Mand Okabe S. 2009. In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells. Environ. Sci. Technol. 43: 6046-6051.
43. Kim JS, Kuk E, Yu KN, Park SJ, Lee HJ, Kim SH, Park YH, Hwang CY. 2007. Antimicrobial effects of silver nanoparticles. Nanomedicine 3: 95-101.
44. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon HI, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20: 575-583.
45. Knowles BB, Howe CC, Aden DP. 1980. Human hepatocellular carcinoma cell line secrete the major plasma proteins and hepatitis B surface antigen. Science 209: 479-499.
46. Lamy E, Kassie F, Gminski R, Schmeiser HH, Mersch-Sundermann V. 2004. 3-Nitrobenzanthrone (3-NBA) induced micronucleus formation and DNA damage in human hepatoma (HepG2) cells. Toxicol. Lett. 146: 103-109.
47. Lok CN, Ho CM, Chen R, Sun H, Tam PK, Chiu JF, Che CM. 2006. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res. 5: 916-924.
48. Mackay ME, Tuteja A, Duxbury PM, Hawker CJ, van Horn B, Chen G, Krishnan RS. 2006. General strategies for nanoparticle dispersion. Science 311: 1740-1743.
49. Marselos M, Storm S, Michalopoulos G. 1987. Effect of Phenobarbital and 3-methylcholanthrene on aldehydehydrogenase activity in HepG2 cells and normal hepatocytes. Chem. Biol. Interact. 62: 75-88.
50. st century in a regulatory context: Another Ames test? or a new edition of 'the red book"? Toxicol. Sci. 108: 19-21.
51. Merrill CL, Ni H, Yoon LW, Tirmenstein MA, Narayanan P, Benavides GR, Easton M, Creech D, Hu C, McFarland D, Hahn L, Thomas HC, Morgan KT. 2002. Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically. Toxicol. Sci. 68: 93-101.
52. Min KS. 2007. Physiological significance of metallothionein in oxidative stress. Yakugaku Zasshi 127: 695-702.
53. Nam S, Kim SW, An Y. 2013. No evidence of the genotoxic potential of gold, silver, zinc oxide and titanium dioxide nanoparticles in the SOS chromotest. J. Appl. Toxicol. 33: 1061-1069.
54. National Research Council (NRC). 2007. Toxicity Testing in the Twenty-First Century: A Vision and a Strategy. National Academies Press: Washington, DC.
55. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311: 622-627.
56. O'Brien J, Wilson I, Orton T, Pognan F. 2000. Invesigation of the Alamar Blue (resazurine) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267: 5421-5426.
57. O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, Gao B, Kaludercic N, Angeline A, Bernardi P. 2006. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 80: 580-604.
58. OECD. 2010. In Vitro Mammalian Cell Micronucleus Test, OECD Guidelines for the Testing of Chemicals, 487, adopted 22 July 2010, OECD, Paris.
59. Piao MJ, Kang KA, Lee IK, Kim HS, Choi YJ, Hyun JW. 2011. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol. Lett. 201: 92-100.
60. Pascarelli NA, Moretti E, Terzuoli G, Lamboglia A, Renieri T, Fioravanti A, Collodel G. 2013 Effects of gold and silver nanoparticles in cultured human osteoarthritic chondrocytes. J. Appl. Toxicol. 33: 1506-1513.
61. Poirier M, Simard J, Antoine F, Girard D. 2013. Interaction between silver nanoparticles of 20nm (AgNP20) and human neutrophils: induction of apoptosis and inhibition of de novo protein synthesis by AgNP20 aggregates. J. Appl. Toxicol. DOI: 10.1002/jat.2956.
62. Powers CM, Badireddy AR, Ryde IT, Seidler FJ, Slotkins TA. 2011. Silver nanoparticles compromise neurodevelopment in PC12 cells: Critical contributions of silver ion, particle size, coating and composition. Environ. Health Perspect. 119: 37-44.
63. Roe AL, Snawder JE, Benson RW, Roberts DW, Casciano DA. 1993. HepG2 cells: an in vitro model for P45-dependent metabolism of acetaminophen. Biochem. Biophys. Res. Commun. 190: 15-19.
64. Sager T, Porter DW, Robinson VA, Lindsley WG, Schwegler-Berry D, Castranova V. 2007. Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 1, 118-129.
65. Sahu SC, Gaines DW, Williams KM, Raybourne RB. 2007. A synthetic polypeptide based on human E-cadherin inhibits invasion of human intestinal and liver cell lines by Listeria Monocytogenes. J. Med. Microbiol. 56: 1011-1016.
66. Sahu SC, Amankwa-Sakyi M, O'Donnell MW, Sprando RL. 2012. Effects of usnic acid exposure on human hepatoblastoma HepG2 cells in culture. J. Appl. Toxicol. 32: 722-730.
67. Sahu SC, Zheng J, Graham L, Chen L, Ihrie J, Yourick JJ, Sprando RL. 2014. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J. Appl. Toxicol. DOI: 10.1002/jat.2994 [Epub ahead of print].
68. Sassa S, Sugita O, Galbraith R, Kappa A. 1987. Drug metabolism by the human hepatoma cell, HepG2. Biochem. Biophys. Res. Commun. 143: 52-57.
69. Schoonen WG, de Roos JA, Westerink WM, Debiton E. 2005a. Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. II mechanistic assays on NAD(P)H, ATP and DNA contents. Toxicol. In Vitro 19: 491-503.
70. Schoonen WG, Westerink WM, de Roos JA, Debiton E. 2005b. Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake. Toxicol. In Vitro 19: 505-516.
71. Shao JM, White CC, Dabrowski MJ, Kavanagh TJ, Eckert ML, Gallagher EP. 2008. The role of mitochondrial and oxidative injury in BDE 47 toxicity to human fetal liver hematopoietic stem cells. Toxicol. Sci. 101: 81-90.
72. Shimoda R, Achanzar WE, Qu W, Nagamine T, Takagi H, Mori M, Waalkes MP. 2003. Metallothionein Is a Potential Negative Regulator of Apoptosis. Toxicol. Sci. 73: 294-300.
73. Sondi I, Salopek-Sondi B. 2004. Silver nanoparticles as antimicrobial agents: A case study on E. Coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275: 177-182.
74. Song W, Zhang J, Guo J, Zhang J, Ding F, Li L, Sun Z. 2010. Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol. Lett. 199: 389-397.
75. Stroegger T, Reinhard C, Karg E, Ritter B, Heyder J, Schulaz H. 2006. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ. Health Prospect. 114: 328-333.
76. Tsui MT, Wang W. 2007. Biokinetics and tolerance development of toxic metals in Daphnia magna. Environ. Toxicol. Chem. 26: 1023-1032.
77. van Dartel DAM, Pennings JLA, de la Fonteyne LJJ, Brauers KJJ, Claessen S, van Delft JH, Kleinjans JCS, Piersma AH. 2011. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures. Toxicol. Sci. 119: 126-134.
78. st century paradigm for evaluating the health hazards of nanoscale materials? Toxicol. Sci. 110: 251-254.
79. Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Gaarf D. 2008. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol. Sci. 105: 97-105.
80. Xu L, Li X, Takemura T, Hanagata N, Wu G, Chou LL. 2012. Genotoxicity and molecular response of silver nanoparticle (NP)-based hydrogel. J. Nanobiotechnol. 10: 16.
81. Xue Y, Zhang S, Huang Y, Zhang T, Liu X, Hu Y, Zhang Z, Tang M. 2012. Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J. Appl. Toxicol. 32: 890-899.
82. Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H. 2000. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci. 10: 195-204.